Probiotics prevent pegylated liposomal doxorubicin-associated hand-foot syndrome and oral mucositis of breast cancer patients following surgery and chemotherapy: a randomized placebo-controlled trial
Probiotics supplement during PLD-based chemotherapy prevents the incidence and severity of HFS and OM, which may be associated with modulating plasma metabolites including the MDO.
Authors
- Zhang Juan
- Jie Chen (ORCID: https://orcid.org/0000-0002-4029-4192)
- Liang Yongping (ORCID: https://orcid.org/0000-0003-1510-5991)
- Boni Ding (ORCID: https://orcid.org/0000-0003-1319-1398)
- Haifeng Cai
- Yong Cheng (ORCID: https://orcid.org/0000-0003-2137-7045)
- Ling Wang (ORCID: https://orcid.org/0000-0002-0059-2232)
- Wen Ouyang (ORCID: https://orcid.org/0000-0002-8596-2537)
- Jingcheng Shi (ORCID: https://orcid.org/0000-0001-8071-5927)
- Jianbin Tong (ORCID: https://orcid.org/0000-0002-2212-6929)
- Hui Chen (ORCID: https://orcid.org/0000-0002-6634-7635)
- Daqing Ma
- Yuhui Wu (ORCID: https://orcid.org/0009-0007-9492-7649)
- Yuan Le
Institutions
- Union Hospital (HK)
- Central South University (CN)
- Changsha Medical University (CN)
- Tangshan People's Hospital (CN)
- Chelsea and Westminster Hospital (GB)
- Centre of Experimental Medicine of the Slovak Academy of Sciences (SK)
- Third Xiangya Hospital (CN)
- Xiangya Hospital Central South University (CN)
- Imperial College London (GB)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- International Journal of Surgery
- Published
- 2024-12-23
- DOI
- https://doi.org/10.1097/js9.0000000000002147
- Citations
- 7
- Primary Topic
- Oral health in cancer treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.93